江苏区域创新能力跃升至全国第二，特别是基础研究取得新的突破，苏州实验室升级为国家实验室，五年来共有6项成果入选"中国科学十大进展"。与"十 三五"末相比，全省高新技术企业数量增长超70%，近九成的专利授权由企业创造、超八成的科技平台和高层次人才都在企业。制造业高质量发展指数连 续五年全国领先，国家先进制造业集群数量居全国第一。动力电池、新型电力装备、集成电路、节能环保、生物医药、软件、海工装备、轨道交通装备等 战略性新兴产业规模位居全国第一。全省未来产业核心企业总数超3100家，营收规模超7500亿元，占战略性新兴产业比重约10%左右。其中，合成生物、 新型储能、氢能等产业整体发展水平全国领先。"江苏制造"叫得更响：从C919大飞机的关键部件，到全球领先的盾构机；从新能源汽车到智能家电，江 苏制造的身影已经遍布全球。 江豚、东方白鹳……珍稀物种齐聚江苏 江苏做好"区域互补、跨江融合、南北联动"大文章。长江经济带和长三角一体化发展联动推进，比如说长江江苏段只占长江通航里程的1/7、承担的货运 量占到了70%，长三角生态绿色一体化发展示范区成为跨区域协作的生动样板。南北结对帮扶，差距不断缩小。统筹推进新型城镇化和 ...

Core Viewpoint - The renaming of Xiaoshan Linjiang High-tech Industrial Development Zone to Hangzhou Qiantang High-tech Industrial Development Zone signifies a profound evolution in regional development logic, transitioning from a geographical concept to an industrial capability focus [1][3]. Group 1: Historical Context - The original name "Xiaoshan Linjiang High-tech Zone" reflects a history of entrepreneurship starting from 2003, evolving into a national-level high-tech zone by 2015, despite its initial small area of 3.55 square kilometers [3]. - The establishment of Qiantang New District in 2020 expanded the management area to 531.7 square kilometers, marking a nearly 150-fold physical expansion and a shift in development strategy from isolated park operations to integrated resource utilization [3][4]. Group 2: Development Trajectory - Qiantang High-tech Zone has shown a significant upward trajectory in its national ranking, moving from 138th in 2019 to 69th in 2024, reflecting a cumulative improvement of 69 positions over five years [6]. - The industrial output value of Qiantang is projected to exceed 370 billion yuan in 2024, maintaining its position as the top contributor in Hangzhou for six consecutive years, with over 85% of this output concentrated in five key industries: automotive, pharmaceuticals, semiconductors, chemicals, and aerospace [6][7]. Group 3: Innovation and Future Development - Qiantang is focusing on enhancing its advanced manufacturing cluster through a "296X" plan, which aims to integrate new and traditional industries while fostering emerging sectors like synthetic biology and low-altitude economy [7][9]. - The region is home to Zhejiang's largest higher education park, with 14 universities and 250,000 students, providing a rich source of intellectual resources, although challenges remain in translating academic research into practical applications [10][11]. - A "dual-direction" integration mechanism has been established to connect academic research with industry needs, including initiatives like the "Doctor into Enterprise" program and the creation of industry colleges to address skill shortages [11][12]. Group 4: Strategic Significance - The renaming reflects a strategic shift from merely establishing a high-tech zone to using it as an engine for driving a new industrial city, emphasizing the need for a modern industrial system in Hangzhou [4][9]. - The mission of Qiantang High-tech Zone is to serve as a key engine for cultivating "new productive forces" while leveraging its unique advantages as a composite platform integrating various economic zones [12].

以往，酵母细胞计数或通过人工使用显微镜完成，或通过非自动化的传统设备完成，存在费时费力又不 够精准的问题。"市场上精酿啤酒质量、口感参差不齐，就在于一些企业细胞计数的不精准，甚至干脆 省去这一环节。"潘登直言。 □ 本报记者许雯斐 通讯员耿瑞雪王若宇 12月3日晚9点，南京酵富生物技术有限公司(以下简称"酵富生物")创始人潘登风尘仆仆地从外地赶回南 京，便径直返回公司进行盘点。这次当天往返的紧急出差，源于客户对新产品的迫切需求。 酵富生物位于江北新区智能制造产业园，就在近日，其推出颠覆啤酒酿造行业的新产品，全量全自动酵 母细胞计数仪JFYCC-S1，该仪器仅需五分钟即可完成从取样到生成报告的全流程。 潘登此次出差，正是去帮客户调试刚订购的新设备。"我们在全国有1000多家客户，得知我们推出这一 新产品，很多客户主动联系订购。"潘登说。 酵母是神奇的酿酒"魔法师"，通过精准调控温度与菌群配比，可以生成不同风味物质，例如酯类产生果 香，酚类带来花香。当代人追捧各式精酿啤酒的迷人风味，正是酵母在其中扮演关键角色。 一罐啤酒发酵时，工作中的酵母细胞数量可达百亿级。而酵母细胞数会影响啤酒风味和发酵的稳定，因 此，唯有精 ...

| 名称 | 成立时间 | | 轮次 | 金额 | | | --- | --- | --- | --- | --- | --- | | 柏垠生物 | 2021年 | 合成生物企业 | 战略融资 | 未披露 | 包括富华资本、广药资本及 | | | | | | | 鲸犀投资 | | 恩泽康泰 | 2017年 | 外泌体科技企业 | B轮 | 近亿元 | 中博聚力领投 | | 臻奏生物 | 2023年 | 医美材料研发商 | Pre-A轮 | 未披露 | 昆山高新集团 | | Xinú | 2017年 | 墨西哥高端香水品 牌 | 股权投资 | 未披露 | 雅诗兰黛宣布通过旗下战略 早期投资部门New Incubation Ventures | | | | | | | A (NIV) | | 修实生物 | 2020年 | 深耕多肽生物合成 领域 | A轮 | 近亿元 | 创景资本领投 | | 巨微生物 | 2024年 | 合成生物技术研发 | A+轮 | | | | | | 問 | | 未披露 | 包括金科君创 | | LAN 兰 | 2019年 | 中国纯净护肤品牌 | 少数股权投资 | 未披露 | 欧莱雅中国 ...

Core Insights - China's innovative drugs, new energy vehicles, and AI electronic products have emerged as the new three major export items, with innovative drug licensing output reaching $93.7 billion in the first three quarters of 2025, accounting for nearly 40% of the global total, reflecting the strong momentum of China's high-quality development [1][24]. Group 1: Major Technological Achievements - The launch of the National Bio-Manufacturing Industry Innovation Center, led by the Shenzhen Institute of Advanced Technology, marks China's only national-level innovation platform in the bio-manufacturing sector, focusing on green low-carbon, bio-agriculture, and medical health [3]. - The completion of the second phase of the Seventh Affiliated Hospital of Sun Yat-sen University in Shenzhen, a modern hospital designed with a patient-centered approach, aims to enhance healthcare innovation in the region [5]. - The Shenzhen Science and Technology Innovation Fund officially commenced operations, aiming to support original innovation and technology breakthroughs through early-stage investments [7]. Group 2: Infrastructure and Collaboration - The establishment of user committees for major scientific infrastructures like synthetic biology research facilities and brain analysis facilities will ensure efficient operation and high-level research output [9]. - The unveiling of the Regional Technology Transfer and Transformation Center for Higher Education Institutions in the Guangdong-Hong Kong-Macao Greater Bay Area will accelerate the conversion of academic research into practical applications [11]. - The emphasis on open collaboration has led to the formation of a global innovation network, enhancing regional cooperation and attracting international research institutions to participate in the development of the Guangming Science City [12]. Group 3: Talent and Innovation Ecosystem - Over the past seven years, Guangming Science City has attracted more than 3,100 high-level talents, including 59 academicians, forming a robust talent pool that supports innovation in fields like brain science and artificial intelligence [24]. - The establishment of a comprehensive open-sharing mechanism for major scientific infrastructures has allowed over 200 users, including universities and research institutions, to access advanced research facilities [25]. - The rise of industrial innovation has led to the development of several billion-dollar industry clusters, including high-end medical devices and synthetic biology, fostering a deep integration of technological and industrial innovation [26].

济宁高新区合成生物产业发展交流会。 核芯医药企业场景。 生命科学中心提供载体支撑。 于伟通讯员吴丛赵相炎济宁报道 合成生物学是一门前沿学科,也是生物制造产业的创新源头。国家"十五五"规划提出"前瞻布局未来产 业",将生物制造这一未来产业列为新的经济增长点。 作为国家级生物技术产业基地,济宁高新区紧跟国家战略,将合成生物作为医药健康产业重点突破领域,出 政策、引人才、建平台、设基金……正全力竞逐新质生产力新赛道。 1 院士领衔 转化成果高效落地 位于济宁高新区的核芯医药(山东)有限公司(以下简称"核芯医药")的生产车间,正进行DHA藻油产品的试 生产,而该产品正是合成生物产业转化成果落地项目之一。 "我们与南京师范大学黄和院士团队签约合作,作为承接黄院士团队合成生物学研发成果的转化基地,目前 DHA藻油项目已率先落地。"核芯医药常务副总经理袁海滨指着企业园区规划图介绍,"这个车间改造后, 现有四个生物发酵罐,专门用于DHA藻油产品生产,目前已进入到最后的试生产阶段,预计在明年实现量 产,前期产量预计约1000吨,整个立项规模可达到3750吨/年。" DHA藻油,是通过生物合成手段,利用特定菌发酵获得,相比传统鱼 ...

济宁高新区党工委书记、管委会主任王亚栋告诉记者，该区已高标准规划建设合成生物产业园，设立产 业发展基金，重点支持菌种创制、发酵工艺等核心环节攻关，通过构建"技术研发—场景应用—产业落 地"的闭环生态，聚力打造合成生物产业核心承载区与技术应用高地。 布局新赛道，济宁高新区的产业基础早已为合成生物的生根发芽备好了肥沃的土壤。作为国家级生物技 术产业基地，这里集聚了鲁抗医药、核芯医药、辰欣药业等一批龙头企业，逐步构建起从研发创新到规 模化制造的完整产业链。同时，先天的交通物流优势让产业发展如虎添翼。济宁高新保税物流中心 以"一站式通关、一体化监管"高效服务，进口环节支持企业将货物暂存中心、延缓缴纳关税等相关税费 并按需分批提货，出口环节允许企业在高新区完成报关、查验等流程，货物存入即视同出口，便捷享受 退税政策，大幅降低企业物流与时间成本。 11月25日，"智汇合成 驱动未来"合成生物产业发展交流会在济宁高新区举办，行业目光聚焦这片合成 生物产业的新兴之地。作为参会嘉宾，中国工程院院士、南京师范大学副校长黄和现场带来专题报告， 结合自身研究领域指出，合成生物学以微生物资源开发利用为核心，通过代谢工程调控与微生物改造 ...

11月25日，第十四届中国创新创业大赛合成生物与生物制造专业赛决赛在常州举行。本次大赛精准 聚焦常州重点布局的"6+X"未来产业赛道，以赛事为平台，面向全国遴选并吸引合成生物领域顶尖人才 与优质项目，为培育新质生产力、构建未来产业竞争力注入强劲动能。 近年来，常州积极抢抓合成生物产业发展风口，今年出台了《常州市加快未来产业培育发展实施方 案（2025—2030年）》，全力打造合成生物产业创新高地，重点支持合成生物各细分领域技术研发、合 成生物产业配套领域全产业发展，以此推动优化产业结构、重塑城市竞争优势。 作为国内规格最高的创新创业赛事，常州已连续承办3届中国创新创业大赛行业全国赛。本届专业 赛吸引95家企业与团队参赛，最终44个前沿项目晋级决赛。为切实推动"创新火花"落地生根，本次大赛 特别设计了"展示+对接+体验"的多元活动矩阵，邀请参赛代表、投融资机构等赴园区实地调研。同 时，提前梳理项目落地、融资、技术等核心诉求，搭建"一对一"深度交流通道，全力促成优质项目与本 地产业生态融合。 ...

Core Insights - The article highlights the development of the Zhoushan Grain Industry Park, which focuses on deep processing of corn and aims to become a hub for synthetic biology and grain oil industry in the Yangtze River Delta region [1][2][3] Group 1: Company Developments - Zhoushan Huakang Biotechnology Co., Ltd. processes corn into various high-value products, significantly increasing their worth by dozens to hundreds of times [1] - The company has invested in a corn deep processing project with a total investment of 2.5 billion yuan, aiming for an annual production capacity of 2 million tons [1] - The first phase of the project is expected to generate an annual output value exceeding 3 billion yuan, while the synthetic biology production line is projected to reach 5 billion yuan [2] Group 2: Industry Growth and Strategy - The Zhoushan Grain Industry Park accounts for nearly 20% of the national import grain logistics volume and has a grain processing capacity of 4 million tons annually, with a processing output value close to 10 billion yuan [1] - The local government is focusing on building a circular economy in the grain oil industry and enhancing the synthetic biology sector, aiming to establish a "large project - industrial chain - industrial cluster" development model [2] - Over 1,000 acres of land have been planned for synthetic biology industry investment, equipped with necessary facilities for wastewater and solid waste treatment [3]

Core Insights - The Ministry of Industry and Information Technology and the National Development and Reform Commission have announced the first batch of biomanufacturing pilot capacity construction platforms, with 43 units selected nationwide [1][2] - The Hangzhou Synthetic Biology Industry Pilot (Validation) Center, operated by Transfar Group in collaboration with state-owned capital, has been recognized as a representative platform in Zhejiang Province [1][2] Group 1: Platform Overview - The pilot center is located in the Xiaoshan Green Manufacturing Industrial Park and focuses on pilot validation and scale-up of synthetic biology technology, covering various fields such as biomanufactured chemicals, enzyme preparations, food, and additives [1][2] - The center aims to create a comprehensive platform integrating technology pilot testing, result validation, process scale-up, and industrial transformation [1][2] Group 2: Technological Capabilities - The center has developed a high-throughput biomanufacturing platform that integrates advanced analytical equipment such as liquid chromatography-mass spectrometry and PCR, enabling core capabilities in strain design, high-throughput testing, and process validation [2] - The application of AI technology in synthetic biology is being actively promoted to support process optimization and parameter control, forming a comprehensive pilot capacity system covering the entire synthetic biology process [2] Group 3: Strategic Goals and Achievements - Transfar Group's Vice President highlighted that being selected as a national pilot platform is a recognition of the company's leading role in continuous innovation and industrial transformation in the biomanufacturing sector [2] - The center has undertaken 11 pilot projects, providing valuable testing grounds for new technologies, processes, and products, effectively accelerating the conversion of scientific research achievements [2] - Future plans include enhancing pilot equipment and services, improving standardization and intelligence levels, and providing replicable models for the industrialization of synthetic biology technology, contributing to the high-quality development of the bio-economy [2]